csirt@kutim:~/threat-intel/cve/CVE-2026-48687

Katalog CVE

CVSS 9.8 · Critical EPSS 2,7%

Kerentanan Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') pada pavel-odintsov fastnetmon. Skor CVSS 3.1 9.8 (Critical) menurut NVD.

Deskripsi (NVD)

FastNetMon Community Edition through 1.2.9 contains an OS command injection vulnerability in the Juniper router integration plugin. The _log() function in src/juniper_plugin/fastnetmon_juniper.php (lines 117-118) constructs shell commands by concatenating the $msg parameter directly into exec() calls: exec("echo `date` \"- {FASTNETMON] - " . $msg . " \" >> " . $FILE_LOG_TMP). The $msg variable contains unsanitized data derived from command-line arguments argv[1] through argv[3], which represent the attack IP address, direction, and power. While FastNetMon's C++ core currently passes IP addresses via inet_ntoa() (which only produces safe dotted-decimal notation), the PHP script performs no input validation or shell escaping. If the script is invoked directly, by another orchestration system, or if future code changes pass string-sourced IPs, arbitrary commands can be injected. The correct fix is to replace exec() with file_put_contents() or use escapeshellarg() on all parameters.

Rincian

Terbit di NVD
26 Mei 2026
Terakhir diubah
21 Juli 2026
Status NVD
Modified
CVSS 3.1
9.8 (Critical), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-78: Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection')
EPSS (30 hari)
2,7% peluang dieksploitasi; lebih tinggi dari 85,2% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
pavel-odintsov fastnetmon Semua versi hingga 1.2.9

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.